Evidence map›Paper›PMID 36418524›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2023

Transitions in depression: if, how, and when depressive symptoms return during and after discontinuing antidepressants.

Arnout C Smit, Evelien Snippe, Laura F Bringmann, H J Rogier Hoenders, Marieke Wichers

Abstract read
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Commentary on "When (Not) to Rely on the Reliable Change Index".Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association · 2024
    Article
  8. Assessing and accounting for measurement in intensive longitudinal studies: current practices, considerations, and avenues for improvement.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arnout C SmitICPE, Department of Psychiatry, University of Groningen, University Medical Center Groningen, Triade Building Entrance 24, HPC CC72, 9700 VB, Groningen, The Netherlands. a.c.smit2@vu.nl.ORCID http://orcid.org/0000-0001-9465-8687
Evelien SnippeICPE, Department of Psychiatry, University of Groningen, University Medical Center Groningen, Triade Building Entrance 24, HPC CC72, 9700 VB, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-3003-7475
Laura F BringmannICPE, Department of Psychiatry, University of Groningen, University Medical Center Groningen, Triade Building Entrance 24, HPC CC72, 9700 VB, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-8091-9935
H J Rogier HoendersCenter for Integrative Psychiatry, Lentis Mental Health Institution, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-5069-0239
Marieke WichersICPE, Department of Psychiatry, University of Groningen, University Medical Center Groningen, Triade Building Entrance 24, HPC CC72, 9700 VB, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-5024-9064

Funding

European Research Council ERC-CoG-2015; No 681466ZonMw Off Road; project 451001029 (40-08125-98-18041)
6 · The paper itself

Abstract

purposeThe aim of the current study is to provide insight into if, how, and when meaningful changes occur in individual patients who discontinue antidepressant medication. Agreement between macro-level quantitative symptom data, qualitative ratings, and micro-level Ecological Momentary Assessments is examined.

methodsDuring and shortly after antidepressant discontinuation, depressive symptoms and 'feeling down' were measured in 56 participants, using the SCL-90 depression subscale weekly (macro-level) for 6 months, and 5 Ecological Momentary Assessments daily (micro-level) for 4 months (30.404 quantitative measurements in total). Qualitative information was also obtained, providing additional information to verify that changes were clinically meaningful.

resultsAt the macro-level, an increase in depressive symptoms was found in 58.9% of participants that (a) was statistically reliable, (b) persisted for 3 weeks and/or required intervention, and (c) was clinically meaningful to patients. Of these increases, 30.3% happened suddenly, 42.4% gradually, and for 27.3% criteria were inconclusive. Quantitative and qualitative criteria showed a very high agreement (Cohen's κ = 0.85) regarding if a participant experienced a recurrence of depression, but a moderate agreement (Cohen's κ = 0.49) regarding how that change occurred. At the micro-level, 41.1% of participants experienced only sudden increases in depressed mood, 12.5% only gradual, 30.4% experienced both types of increase, and 16.1% neither.

conclusionMeaningful change is common in patients discontinuing antidepressants, and there is substantial heterogeneity in how and when these changes occur. Depressive symptom change at the macro-level is not the same as depressive symptom change at the micro-level.

Indexed as

DepressionQuality of LifeAntidepressive AgentsHumansAntidepressive AgentsAntidepressant discontinuationDepressive disorderEcological Momentary AssessmentMeaningful changePersonalized psychiatry

Identifiers

PMID36418524
PMCPMC10123048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.